The Effect of Increases in HMO Penetration and Changes in Payer Mix on In-hospital Mortality and Treatment Patterns for Acute Myocardial InfarctionByKevin G. M. Volpp, MD, PhD,Edward Buckley, MAJuly 1st 2004
Impact of an Educational Intervention for Secondary Prevention of Myocardial Infarction on Medicaid Drug Use and CostByIlene H. Zuckerman, PharmD,Sheila R. Weiss, PhD,Diane McNally, BPharm, MS,Barbara Layne, RN,C. Daniel Mullins, PhD,Junling Wang, MSJuly 1st 2004
The Potential Role of Community-based Registries to Complement the Limited Applicability of Clinical Trial Results to the Community Setting: Heart Failure as an ExampleByJoseph A. Franciosa, MDJuly 1st 2004
Hypertension Management: The Care Gap Between Clinical Guidelines and Clinical PracticeBySusan E. Andrade, ScD,Jerry H. Gurwitz, MD,Terry S. Field, DSc,Michael Kelleher, MD,Sumit R. Majumdar, MD, MPH,George Reed, PhD,Robert Black, MDJuly 1st 2004
Can We Use Automated Data to Assess Quality of Hypertension Care?ByAnn M. Borzecki, MD, MPH,Ashley T. Wong, MA,Elaine C. Hickey, RN, MS,Arlene S. Ash, PhD,Dan R. Berlowitz, MD, MPHJuly 1st 2004
Improving Quality of Cardiovascular Care in the Real World: How Can We Remove the Barriers?ByDebabrata Mukherjee, MD,Kim A. Eagle, MDJuly 1st 2004
Aligning Financial Incentives With "Get With The Guidelines" to Improve Cardiovascular CareByJohn T. Berthiaume, MD,Patricia A. Tyler, RN, CCRN,Jacqueline Ng-Osorio, MPH,Kenneth A. LaBresh, MDJuly 1st 2004
